The next major leg up or down in the biotech sector is likely to be determined by the direction in which these symmetrical triangle patterns break (120-minute charts of IBB & XBI). While I favor a downside resolution, an upside break would likely bring IBB to around the 360 level, about 9 ½% above the current price.